SDIC Fund Management logo

SDIC Fund Management

Asia, Beijing, China, Beijing

Description

SDIC Fund Management is a private equity that manages funds and raises nearly 60 billion yuan at present.

Investor Profile

SDIC Fund Management has made 15 investments, with 6 in the past 12 months and 67% as lead.

Stage Focus

  • Series C (27%)
  • Series B (20%)
  • Series D (20%)
  • Series A (13%)
  • Seed (13%)
  • Series E (7%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Manufacturing
  • Oncology
  • Medical Device
  • Pharmaceutical
  • Automotive
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SDIC Fund Management frequently co-invest with?

Co-Investments: 1
Grand Flight Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
China Chengtong Holding Group
Asia, Beijing, China, Beijing
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Innolink Fund
Asia, Beijing, China, Haidian
Co-Investments: 1
Bain Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 3
Yanchuang Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

Which angels does SDIC Fund Management often collaborate with?

Adrian Cheng
Asia, Hong Kong
Shared Deals: 1

What are some of recent deals done by SDIC Fund Management?

Hipot

Wuhan, Hubei, China

Hipot is a technological innovation company dedicated to providing hydrogen fuel cell commercial vehicle transportation solutions.

LogisticsPublic TransportationTransportation
Series AMar 24, 2025
Amount Raised: $62,035,595
Tianmei Times

Chaoyang, Liaoning, China

Tianmei Times focusing on the fields of spectroscopy, chromatograph and mass spectrometry, life science laboratory equipment, etc.

Life ScienceManufacturingMedical
SeedMar 6, 2025
Weikaier Pharmaceutical Technology

Nanjing, Jiangsu, China

Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals.

BiopharmaBiotechnologyMedical
Series CJan 22, 2025
Amount Raised: $27,502,750
NASN Automotive Electronics

Shanghai, Shanghai, China

NASN Automotive Electronics is a manufactures automotive electronics and driving related core technology products.

AutomotiveElectronicsManufacturing
Series DDec 31, 2024
Amount Raised: $68,510,982
Estun Codroid

Nanjing, Jiangsu, China

Estun Codroid is a company that develops and applies generic intelligent robot technology.

ManufacturingRobotics
SeedNov 11, 2024
Amount Raised: $18,025,263
Calterah

Shanghai, Shanghai, China

Calterah is a designer and developer of CMOS single-chip millimeter-wave radar sensors.

HardwareSemiconductorSensor
Series DJul 2, 2024
Avistone Pharmaceuticals

Beijing, Beijing, China

Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.

BiotechnologyOncology
Series BDec 28, 2023
Amount Raised: $140,686,550
Adlai Nortye

Hangzhou, Zhejiang, China

Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.

BiotechnologyHealth CareOncologyPharmaceutical
Series DJul 13, 2021
Amount Raised: $100,000,000
EpimAb Biotherapeutics

Shanghai, Shanghai, China

EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company.

BiopharmaBiotechnologyHealth CareTherapeutics
Series CMar 22, 2021
Amount Raised: $120,000,000
Zylox

Hangzhou, Zhejiang, China

Zylox is an interventional and implantable peripheral vascular device developer.

BiotechnologyHealth CareMedical Device
Series COct 30, 2020
Amount Raised: $45,000,000